FIELD: veterinary medicine.
SUBSTANCE: invention relates to the field of veterinary medicine. An agent for the treatment of cattle with thelaziosis contains levamisole, florfenicol, dexamethasone and 0.5% novocaine solution. All components are taken at a certain ratio.
EFFECT: invention allows to increase the recovery time of an animal suffering from thelaziosis, as well as to improve the properties of the drug.
1 cl, 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CATTLE THELAZIOSIS IN FIELD CONDITIONS | 2019 |
|
RU2717643C1 |
METHOD OF TREATING CONJUNCTIVITIS IN CATTLE | 2023 |
|
RU2824808C1 |
METHOD OF CATTLE THELAZIOSIS TREATMENT | 2016 |
|
RU2613145C1 |
METHOD OF TREATING TELASIOSES OF ANIMALS | 2010 |
|
RU2426550C1 |
PREPARATION AND METHOD OF COMPLEX TREATMENT OF ANIMALS WITH AFFECTION OF MUCOSA AND SKIN OF DIFFERENT ETIOLOGY | 2012 |
|
RU2535166C2 |
OINTMENT TYPE PANPHARMACON FOR COMPLEX TREATMENT OF ANIMAL EYE DISEASES AND METHOD OF PRODUCING THEREOF | 2017 |
|
RU2667118C1 |
METHOD FOR TREATING CONJUNCTIVO-KERATITIS IN CATTLE | 2004 |
|
RU2268731C1 |
USE OF TETRAHYDROFURANOL-3 AS ANESTHETIC | 2000 |
|
RU2162694C1 |
METHOD OF TREATING INVETERATE LEUKOMA OF CATTLE IN FIELD CONDITIONS | 2019 |
|
RU2722718C1 |
METHOD OF CATTLE CAROTENE-DEFICIENT HEMERALOPIA TREATMENT IN FIELD CONDITIONS | 2019 |
|
RU2729738C1 |
Authors
Dates
2022-06-21—Published
2021-12-27—Filed